| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ARD.60.6.545 |
| P932 | PMC publication ID | 1753659 |
| P2093 | author name string | L B A VAN DE PUTTE | |
| T VISCHER | |||
| P2860 | cites work | Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism | Q24562315 |
| Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases | Q33922157 | ||
| The role of the chondrocyte in osteoarthritis | Q34051076 | ||
| Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees | Q35547258 | ||
| Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood | Q35547425 | ||
| Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage | Q37365557 | ||
| Biochemical markers of bone metabolism | Q37409175 | ||
| Molecular markers of processes in cartilage in joint disease. | Q37632518 | ||
| Monitoring collagen degradation in patients with arthritis. The search for suitable surrogates | Q41116418 | ||
| Can we predict aggressive disease? | Q41410223 | ||
| Studies of a monoclonal antibody to skeletal keratan sulphate. Importance of antibody valency | Q41820839 | ||
| Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study | Q41921976 | ||
| Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis | Q47849262 | ||
| Is bone turnover a determinant of bone mass in rheumatoid arthritis? | Q50851957 | ||
| The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. | Q53988786 | ||
| Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption | Q70483489 | ||
| Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography | Q71475059 | ||
| Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy | Q71880208 | ||
| Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis | Q72068458 | ||
| Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis | Q72402093 | ||
| The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis | Q72547392 | ||
| Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis | Q72871588 | ||
| The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis | Q73203801 | ||
| Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis | Q74046804 | ||
| Chondrex: new marker of joint disease | Q74338979 | ||
| Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products | Q77378538 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 545-545 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | EULAR and its journal | |
| P478 | volume | 60 |
Search more.